Merlin Capital, Inc NTLA Holdings History
Merlin Capital, Inc's Intellia Therapeutics Inc Holding Summary
As of 2024-03-31, Merlin Capital, Inc held 17,724.00 shares of Intellia Therapeutics Inc(NTLA), totaling $487,590.00. This investment constitutes 1.45% of their stock portfolio, and Merlin Capital, Inc now holds 0.02% of the outstanding Intellia Therapeutics Inc(NTLA) stock.
The initial trade took place in 2021Q4. And since then Merlin Capital, Inc has made 7 purchases of NTLA, at an average price of $65.65, for a total of 27,351.00 shares. In addition, there have been 2 sales at an average price of $29.62 for 9,627.00 shares. Based on historical transaction data and NTLA's current price of $11.54, Merlin Capital, Inc's estimated gain on his NTLA holdings is $-1.31 Mil, reflecting a -72.73% gain to date.
Merlin Capital, Inc NTLA ($11.54) Holding Chart
Merlin Capital, Inc NTLA ($11.54) Quarterly Buys and Sells
Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
---|---|---|---|---|
Shares Bought | 0 | Average Price $-/Share | ||
Shares Sold | 0 | Average Price $-/Share | ||
Current Price $0.00 | Total Estimated Gain 0 % |
Top Ranked Articles
- 1